[Immunogenicity and reactogenicity of a reduced antigen content diphtheria, tetanus and
acellular pertussis vaccine dTpa) in 10 to 11 years old children and in adults]. - Abstract - Europe …

Background: New vaccination strategies are needed to control the increasing problem of
pertussis in teenagers and adults. Aim: To determine the immunogenicity and reactogenicity …

Background. The recent introduction of acellular pertussis vaccines (Pa) offers the possibility
of booster doses in older children and adults. This can be conveniently accomplished by …

A trial to compare the reactogenicity and immunogenicity of a reduced antigen content
diphtheria–tetanus–acellular pertussis (dTpa) vaccine with diphtheria–tetanus–whole-cell …

The aim of this assessor-blinded trial was to compare the immunogenicity and reactogenicity
of a candidate diphtheria, tetanus toxoids and acellular pertussis vaccine with reduced …

The present study was undertaken to compare the immunogenicity and reactogenicity of two
diphtheria-tetanus-whole cell pertussis (DTwP) vaccines administered to Iranian preschool …

Objective: To establish safety, immunogenicity, and batch stability of a reformulated whole
cell pertussis based diphtheria‐tetanus‐whole cell pertussis (DTP) vaccine (nDTPw) …

Two clinical studies were undertaken to evaluate the immunogenicity of an adult-type dTpa
booster vaccine (Boostrix™ by GlaxoSmithKline Biologicals). Blood samples taken prior to …

Objective: To evaluate the safety and reactogenicity of a reduced-antigen-content combined
Diphtheria-Tetanus-Acellular Pertussis (dTpa) vaccine in Indian pre-school children …

Pertussis vaccines containing reduced amounts of antigen have been considered primarily
for use in adolescents and adults to date. We evaluated a reduced antigen content …